Today: 19 May 2026
IBM Closes $11 Billion Confluent Deal as Arvind Krishna Says AI Push Could Spur Hiring

IBM Closes $11 Billion Confluent Deal as Arvind Krishna Says AI Push Could Spur Hiring

ARMONK, New York, March 17, 2026, 10:59 EDT

IBM has wrapped up its $11 billion deal for Confluent, folding the data-streaming specialist into its broader enterprise AI and hybrid cloud strategy. IBM stock edged up 1.2% late Tuesday morning in New York. Trading in Confluent’s Class A shares was halted premarket; the stock is set for suspension on March 18.

This is coming to the forefront as firms push to shift AI out of the test lab and into the daily grind — they need real-time data, not last night’s uploads. IBM and Confluent say their joint platform is built to keep fresh data streaming between on-prem and hybrid cloud setups, so AI agents — those apps that can act across business tools with minimal human direction — aren’t stuck working from stale numbers.

Krishna likened Confluent’s technology to the role Red Hat played in IBM’s hybrid-cloud push, calling it the backbone of IBM’s AI plans, the Wall Street Journal reported. IBM, for its part, is sticking with its $4.5 billion productivity gain from AI—an outcome it’s been highlighting as it expands its AI offerings.

IBM listed watsonx.data, MQ, webMethods Hybrid Integration, and IBM Z among the integrations available on day one. “Transactions happen in milliseconds and AI decisions have to move just as fast,” said Rob Thomas, who leads IBM Software. For Confluent, joining IBM opens up bigger ambitions—co-founder and chief executive Jay Kreps said the deal allows Confluent to scale its data-streaming business much further. Confluent claims its platform, which is built on Apache Kafka—the open-source staple for streaming data—is already used by more than 6,500 enterprises, including 40% of the Fortune 500. IBM Newsroom

IBM agreed in December to pay $31 a share for Confluent, marking a 34% premium over the stock’s prior close. The company plans to use existing cash for the acquisition, projecting it will boost adjusted core earnings in the first full year and add to free cash flow by year two. The Confluent transaction comes after IBM’s $6.4 billion HashiCorp purchase last year and its $34 billion buyout of Red Hat in 2019.

IBM’s finish keeps its momentum going in the AI space—a field where heavyweights like Amazon Web Services and Microsoft still dominate on the cloud front. Unlike those giants, IBM has been appealing to businesses looking to deploy AI across several cloud environments or on their own systems, instead of sticking with just one provider.

Krishna rejected claims that AI is just a workforce reducer for IBM. As reported by the Journal, he said there’s been no overall drop in jobs at IBM because of AI, and headcount may even go higher—consulting and tech roles in particular—despite shifts in more routine areas like customer service, software, HR, and payroll.

Analysts get the rationale, but no one’s promising it will pay off. Sanjeev Mohan at SanjMo pointed out that as enterprises shift AI pilots into full-scale production, many hit a data architecture snag—AI agents need current, real-time signals rather than outdated records. IBM’s stack makes the most sense for customers whose systems already play well with that model, Mohan said. For Michael Ashley Schulman at Running Point Capital, Confluent is simply the “critical data firehose” powering the AI surge. IBM, though, flagged that the anticipated upsides of the deal might not materialize. PR Newswire

Stock Market Today

  • India IPO Fundraising Drops to Two-Year Low in Early 2026 with Uncertain Outlook for H2
    May 19, 2026, 6:19 AM EDT. India's IPO fundraising has plunged to Rs 56,322 crore in the first five months of 2026, marking a sharp decline from Rs 82,678 crore in the same period last year and a two-year low, according to Primedatabase. Contributing factors include market volatility, geopolitical tensions, and cautious investor behavior amid global uncertainties. Notably, average subscription rates fell to roughly 2x in early 2026 from 38x in H2 2025, signaling weakened appetite. Despite a healthy pipeline with major listings from NSE and Jio Platforms expected in the second half, experts warn recovery will be cautious and selective. Institutional investors now favor profitable, scalable firms over aggressive growth models. The primary market slowdown contrasts with record 2025 fundraising and raises concerns about H2 momentum.

Latest articles

Hesai Up Premarket After Mercedes Lidar Win, Q1 Profit

Hesai Up Premarket After Mercedes Lidar Win, Q1 Profit

19 May 2026
Hesai Group shares rose 2.68% to $22.60 in U.S. premarket trading after reporting a first-quarter profit and confirming it will supply lidar sensors for Mercedes-Benz Level 3 autonomous models. The company shipped 471,723 lidar units, up 140.9% year-on-year, and posted revenue of RMB680.6 million ($98.7 million). Net income reached RMB18.3 million, reversing a loss from a year earlier.
Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

19 May 2026
Virax Biolabs shares surged 53.1% Monday to $0.2350 and climbed another 17.1% in early Tuesday premarket trading, hitting $0.2751. The rally followed a paid RedChip TV appearance and a May 15 ownership filing showing Armistice Capital with a 4.99% stake. No new clinical or product updates were posted. Trading volume Monday reached about 765.2 million shares.
Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

19 May 2026
Amesite Inc. shares surged 218% to $2.50 in premarket trading after announcing its largest NurseMagic deployment with a 2,700-patient home-care client. The company disclosed $83,332 in quarterly revenue and a $678,061 net loss, with cash at $740,711 before a $2.2 million April financing. Amesite did not reveal the new contract’s value or customer name. Its latest filing cited “substantial doubt” about ongoing operations.

Popular

Intel Shares Edge Up as AI Chip Trade Runs Into Hurdles

Intel Shares Edge Up as AI Chip Trade Runs Into Hurdles

18 May 2026
Intel shares rose 0.3% to $109.10 in early New York trading Monday after last week’s selloff, as analysts raised price targets and President Trump commented on the U.S. government’s 10% stake, now valued above $50 billion. First-quarter revenue climbed 7% to $13.6 billion, with Data Center and AI sales up 22%. The iShares Semiconductor ETF fell 0.9%. Intel’s server CPU market share dropped to 54.9% in Q1, according to UBS.
Nokia Stock Price Today Slips, but AI Push Keeps Shares Near 52-Week High
Previous Story

Nokia Stock Price Today Slips, but AI Push Keeps Shares Near 52-Week High

Dow Jones Today: Fed Looms as Oil Shock Keeps Wall Street on Edge
Next Story

Dow Jones Today: Fed Looms as Oil Shock Keeps Wall Street on Edge

Go toTop